NAS Proposes Phase 2 Clinical Stage Agent Can Be an Effective Treatment and Adjuvant Therapeutic for COVID-19. NAS150 Application Could Also Potentially Be Applied for COVID-19 Central Nervous System Conditions specifically those related to “Long Haul” conditions. Scottsdale, Arizona, December 3rd 2021 – New Amsterdam Sciences, a privately held bioscience company, announces the filing […]